TriSalus Life Sciences, Inc. TLSI Proceeds From Long Term Lines Of Credit
Proceeds From Long Term Lines Of Credit at other companies
Other financials
Where this comes from
Reported directly by TriSalus Life Sciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ProceedsFromLongTermLinesOfCredit.
The official record: TriSalus Life Sciences, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about TriSalus Life Sciences, Inc.'s proceeds from long term lines of credit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is TriSalus Life Sciences, Inc.'s proceeds from long term lines of credit?
- TriSalus Life Sciences, Inc. (TLSI) reported proceeds from long term lines of credit of $0 in Q1 2026.
- How has TriSalus Life Sciences, Inc.'s proceeds from long term lines of credit changed year-over-year?
- TriSalus Life Sciences, Inc.'s proceeds from long term lines of credit decreased by 100.0% year-over-year, from $10M to $0.
- What does proceeds from long term lines of credit mean?
- Indicates the cash inflows generated from drawing down on long-term debt facilities or credit lines. This metric is a primary indicator of how a company manages its external financing to support operations or growth. It provides insight into the company's reliance on debt markets for liquidity.